HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.30 Cr | ₹-14 Cr | ₹15 Cr | ₹3.80 Cr | ₹-24 Cr |
What is the latest Net Cash Inflow / Outflow ratio of HIKAL ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹0.30 Cr |
| Mar2024 | ₹-14 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹3.80 Cr |
| Mar2021 | ₹-24 Cr |
How is Net Cash Inflow / Outflow of HIKAL Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.30 Cr | Positive | |
| Mar2024 | ₹-14 Cr | Negative | |
| Mar2023 | ₹15 Cr | 301.92 | |
| Mar2022 | ₹3.80 Cr | Positive | |
| Mar2021 | ₹-24 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,806.9 Cr | -6.1% | 2.4% | -38.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,590.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,577.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,301.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹120,471.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,660.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -6.1% |
2.4% |
-38.3% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses